Summary
Brain microdialysis was used to localize the mechanism of action of the effect induced by the D-2 agonists (−)-2-(N-propyl-N-2-thienylethylamino)-5-hydroxytetralin [(−)-N-0437] and (+)-4-propyl-9-hydroxynaphtoxazine [(+)-PHNO], on the release of DA in the striatum. Both agonists induced a stronger decrease in the release of DA when administered systemically in comparison to local administration. This suggests that the action of D-2 agonists is not exclusively mediated by autoreceptors regulating the release of DA at the level of the nerve terminals. By co-infusing nomifensine (10 µM) the effect of intrastriatally administered D-2 agonists on the release of DA could be completely abolished. As both agonists were effective when administered systemically in normal rats and in rats with kainic acid lesions performed in the striatum during nomifensine infusion, the effects induced by D-2 agonists seem to be partly mediated by autoreceptors situated on cell bodies, regulating the impulse flow of the neuron. In addition, D-2 receptors located on postsynaptic structures participating in the striatonigral feedback loops were suggested to be involved. (−)-N-0437 and (+)-PHNO were less effective after systemic administration when kainic acid lesioned rats were used in comparison with normal rats. Thus, D-2 agonists interact in a complex way with D-2 receptors for displaying their effect on the release of DA: autoreceptors situated on nerve terminals and on cell bodies as well as D-2 receptors located on postsynaptic structures participating in the striatonigral neuronal loops may all be involved to a certain extent in the mechanism of action of D-2 agonists.
Similar content being viewed by others
References
Bunney BS, Walters JR, Roth RH, Aghajanian GK (1973) Dopaminergic neurons: effects of antipsychotic drugs and amphetamine on single cell activity. J Pharmacol Exp Ther 185:560–571
Carlsson A, Lindqvist M (1963) Effect of chlorpromazine or haloperidol on formation of 3-methoxytyramine and normetanephrine in mouse brain. Acta Pharmacol 20:140–144
Coyle JT, Molliver ME, Kuhar MJ (1978) In site injection of kainic acid: a new method for selectively lesioning neuronal cell bodies while sparing axons of passage. J Comp Neurol 180:301–323
Cubeddu LX, Hoffmann IS (1982) Operational characteristics of the inhibitory feedback mechanism for regulation of dopamine release via presynaptic receptors. J Pharmacol Exp Ther 223:497–501
Damsma G, Westerink BHC, Imperato A, Rollema H, De Vries JB, Horn AS (1987) Automated brain microdialysis of acetylcholine in freely moving rats: detection of basal acetylcholine. Life Sci 41:873–876
Di Chiara G, Porceddu ML, Fratta W, Gessa GL (1977) Postsynaptic receptors are not essential for dopaminergic feedback regulation. Nature 267:270–272
Farnebo LO, Hamberger B (1971) Drug-induced changes in the release of 3H-monoamines from field-stimulated rat brain slices. Acta Physiol Scand Suppl 371:35–44
Groves PM, Wilson CJ, Young SJ, Rebec GV (1975) Self-inhibition by dopaminergic neurons. Science 190:522–528
Hattori T, McGeer EG (1977) Fine structural changes in the rat striatum after local injections of kainic acid. Brain Res 129:174–180
Hoffmann IS, Cubeddu LX (1982) Rate and duration of stimulation determine presynaptic effects of haloperidol on dopaminergic neurons. J Neurochem 39:585–588
Horn AS, Hazelhoff B, Dijkstra D, De Vries JB, Mulder TBA, Timmermans P, Wijnberg H (1984) The hydroxy-hexahydronaphtoxazines: a new group of very potent and selective dopamine agonists. J Pharm Pharmacol 36:639–640
Imperato A, Di Chiara G (1984) Trans-striatal dialysis coupled to reverse phase high performance liquid chromatography with electrochemical detection: a new method for the study of endogenous dopamine and metabolites. J Neurosci 4:966–977
Imperato A, Di Chiara G (1985) Dopamine release and metabolism in awake rats after systemic neuroleptics as studied by trans-striatal dialysis. J Neurosci 5:297–306
Kehr W, Carlsson A, Lindqvist M, Magnusson T, Atack CV (1972) Evidence for a receptor mediated feedback control of striatal tyrosine hydroxylase activity. J Pharm Pharmacol 24:744–747
Konig JFR, Klippel RA (1963) The rat brain: a stereotaxic atlas of the forebrain and lower parts of the brainstem. Williams and Wilkins, Baltimore
Martin GE, Williams M, Pettibone DJ, Zrada MM, Lotti VJ, Taylor DA, Jones JH (1985) Selectivity of (+)-4-propyl-9-hydroxy-naphtoxazine [(+)-PHNO] for dopamine receptors in vitro and in vivo. J Pharmacol Exp Ther 233:395–401
Timmerman W, Rusk IN, Tepper PG, Horn AS, Cooper SJ (1989) The effects of the enantiomers of the dopamine agonist N-0437 on food consumption and yawning behaviour in rats. Eur J Pharmacol 174:107–114
Van Der Weide J, Tendijck MEC, Epper G, De Vries JB, Dubocovich ML, Horn AS (1988) The enantiomers of the D-2 receptor agonist N-0437 discriminate between pre- and post-synaptic dopamine receptors. Eur J Pharmacol 146:319–326
Westerink BHC, Tuinte MHJ (1986) Chronic use of intracerebral dialysis for the in vivo measurements of 3,4-dihydroxyphenylethylamine and its metabolite 3,4-dihydroxyphenylacetic acid. J Neurochem 46:181–185
Westerink BHC, De Vries JB (1989) On the mechanism of neuroleptic induced increase in striatal dopamine release: brain microdialysis provides evidence for mediation by autoreceptors localized on nerve terminals. Neurosci Lett 99:197–202
Westerink BHC, Damsma G, Rollema H, De Vries JB, Horn AS (1987a) Scope and limitations of in vivo brain microdialysis: a comparison of its application to various transmitter systems. Life Sci 41:1763–1776
Westerink BHC, Tuntler J, Damsma G, Rollema H, De Vries JB (1987b) The use of tetradotoxin for the characterization of drug-enhanced dopamine release on conscious rats studied by brain microdialysis. Naunyn-Schmiedeberg's Arch Pharmacol 336:502–507
Zetterstrom T, Sharp T, Marsden CA, Ungerstedt U (1983) In vivo measurements of dopamine and its metabolites by intracerebral dialysis: changes after d-amphetamine. J Neurochem 41:1769–1773
Zetterstrom T, Sharp T, Ungerstedt U (1984) Effect of neuroleptic drugs on striatal dopamine release and metabolism in the awake rat studied by intracerebral dialysis. Eur J Pharmacol 106:27–37
Author information
Authors and Affiliations
Additional information
Send offprint requests to W. Timmerman at the above address
Rights and permissions
About this article
Cite this article
Timmerman, W., De Vries, J.B. & Westerink, B.H.C. Effects of D-2 agonists on the release of dopamine: localization of the mechanism of action. Naunyn-Schmiedeberg's Arch Pharmacol 342, 650–654 (1990). https://doi.org/10.1007/BF00175707
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00175707